Vasopressin as Therapy During Nonocclusive Mesenteric Ischemia

Annals of Thoracic Surgery

Volumn 102, Issue 3, 2016, Pages 813-819

  Bomberg, Hagen ^a   Groesdonk, Heinrich V ^a   Raffel, Miriam ^a   Minko, Peter ^a   Schmied, Wolfram ^a   Klingele, Matthias ^a   Schäfers, Hans Joachim ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; ILOPROST; LACTIC ACID; MILRINONE; NORADRENALIN; PROSTAVASIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ADJUVANT THERAPY; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CAUSE OF DEATH; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG INFUSION; DRUG MEGADOSE; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HOSPITAL CARE; HUMAN; INTESTINE PERFUSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ISCHEMIA; NONOCCLUSIVE MESENTERIC ISCHEMIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SUPERIOR MESENTERIC ANGIOGRAPHY; SURVIVAL RATE; VASODILATATION; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; MALE; MESENTERIC ISCHEMIA; MIDDLE AGED; NOREPINEPHRINE; VASOPRESSINS;

EID: 84975153675     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.03.025     Document Type: Article

References (32)

1. 1 Trompeter, M., Brazda, T., Remy, C.T., Vestring, T., Reimer, P., Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol 12 (2002), 1179–1187.
2. 2 Minko, P., Groesdonk, H., Stroeder, J., et al. A scoring system for the assessment of angiographic findings in non-occlusive mesenteric ischemia (NOMI). Rofo 184 (2012), 805–809.
3. 3 Clark, J.A., Coopersmith, C.M., Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock 28 (2007), 384–393.
4. 4 Ince, C., The microcirculation is the motor of sepsis. Crit Care 9 Suppl 4 (2005), S13–S19.
5. 5 Carl, M., Alms, A., Braun, J., et al. S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci, 8, 2010 Doc12.
6. 6 Maier, S., Hasibeder, W., Pajk, W., et al. Arginine-vasopressin attenuates beneficial norepinephrine effect on jejunal mucosal tissue oxygenation during endotoxinaemia. Br J Anaesth 103 (2009), 691–700.
7. 7 Salak, N., Pajk, W., Knotzer, H., et al. Effects of epinephrine on intestinal oxygen supply and mucosal tissue oxygen tension in pigs. Crit Care Med 29 (2001), 367–373.
8. 8 Groesdonk, H.V., Klingele, M., Schlempp, S., et al. Risk factors for nonocclusive mesenteric ischemia after elective cardiac surgery. J Thorac Cardiovasc Surg 145 (2013), 1603–1610.
9. 9 Benbenishty, J., Weissman, C., Sprung, C.L., Brodsky-Israeli, M., Weiss, Y., Characteristics of patients receiving vasopressors. Heart Lung 40 (2011), 247–252.
10. 10 Argenziano, M., Chen, J.M., Choudhri, A.F., et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998), 973–980.
11. 11 Torgersen, C., Dunser, M.W., Wenzel, V., et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med 36 (2010), 57–65.
12. 12 Hiltebrand, L.B., Krejci, V., Jakob, S.M., Takala, J., Sigurdsson, G.H., Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 106 (2007), 1156–1167.
13. 13 Bomberg, H., Bierbach, B., Flache, S., et al. Endothelin and vasopressin influence splanchnic blood flow distribution during and after cardiopulmonary bypass. J Thorac Cardiovasc Surg 145 (2013), 539–547.
14. 14 Tao, W., Zwischenberger, J.B., Nguyen, T.T., et al. Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 110 (1995), 819–828.
15. 15 Landry, D.W., Oliver, J.A., The pathogenesis of vasodilatory shock. N Engl J Med 345 (2001), 588–595.
16. 16 Hirsch, A.T., Haskal, Z.J., Hertzer, N.R., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006), e463–e654.
17. 17 Khan, T.A., Bianchi, C., Ruel, M., Feng, J., Sellke, F.W., Differential effects on the mesenteric microcirculatory response to vasopressin and phenylephrine after cardiopulmonary bypass. J Thorac Cardiovasc Surg 133 (2007), 682–688.
18. 18 O'Dwyer, C., Woodson, L.C., Conroy, B.P., et al. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg 63 (1997), 728–735.
19. 19 Oliver, G., Schafer, E.A., On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication. J Physiol 18 (1895), 277–279.
20. 20 Russell, J.A., Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care, 15, 2011, 226.
21. 21 Bomberg, H., Bierbach, B., Flache, S., et al. Vasopressin aggravates cardiopulmonary bypass-induced gastric mucosal ischemia. Eur Surg Res 54 (2015), 75–86.
22. 22 Bomberg, H., Bierbach, B., Flache, S., et al. Vasopressin induces rectosigmoidal mucosal ischemia during cardiopulmonary bypass. J Card Surg 29 (2014), 108–115.
23. 23 Baumann, G., Dingman, J.F., Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest 57 (1976), 1109–1116.
24. 24 Kluge, M., Riedl, S., Erhart-Hofmann, B., Hartmann, J., Waldhauser, F., Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children. Clin Chem 45 (1999), 98–103.
25. 25 Robertson, G.L., Mahr, E.A., Athar, S., Sinha, T., Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52 (1973), 2340–2352.
26. 26 Novella, S., Martinez, A.C., Pagan, R.M., et al. Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 32 (2007), 69–76.
27. 27 Philbin, D.M., Levine, F.H., Emerson, C.W., Coggins, C.H., Buckley, M.J., Austen, W.G., Plasma vasopressin levels and urinary flow during cardiopulmonary bypass in patients with valvular heart disease: effect of pulsatile flow. J Thorac Cardiovasc Surg 78 (1979), 779–783.
28. 28 Wittwer, E.D., Lynch, J.J., Oliver, W.C. Jr., Dearani, J.A., Burkhart, H.M., Mauermann, W.J., The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin concentrations. J Thorac Cardiovasc Surg 148 (2014), 625–630.
29. 29 Groesdonk, H.V., Raffel, M., Speer, T., et al. Elevated endothelin-1 level is a risk factor for nonocclusive mesenteric ischemia. J Thorac Cardiovasc Surg 149 (2015), 1436–1442.e2.
30. 30 Nankervis, C.A., Schauer, G.M., Miller, C.E., Endothelin-mediated vasoconstriction in postischemic newborn intestine. Am J Physiol Gastrointest Liver Physiol 279 (2000), G683–G691.
31. 31 Nazari, A., Sadr, S.S., Faghihi, M., et al. Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts. Eur J Pharmacol 760 (2015), 96–102.
32. 32 Serpa Neto, A., Nassar, A.P., Cardoso, S.O., et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care, 16, 2012, R154.